Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04729504 · ClinicalTrials.gov registry record · NA

Cultural Adaptation of a SSI for Youth Anxiety

A NA study of Anxiety Disorders, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
2,000
Enrollment target
1
Study location

NCT04729504 is a NA study of Anxiety Disorders that is actively recruiting participants, run by University of Miami. The registered enrollment target is 2,000 participants, above the 1,116-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04729504, a NA study of Anxiety Disorders, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target
1
Study location

Study Summary

The overarching objective of this protocol is to (1) adapt and (2) disseminate an evidence-based, brief (approximately 30 minute) single session intervention (SSI) to better reflect the cultural and linguistic diversity of Latin, Haitian, and Haitian-American individuals via a fully online platform.

Conditions Studied

Interventions

  • BEHAVIORAL Adapted Project BRAVE

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2021-03-08
Est. Completion 2026-12-21
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT04729504

The ClinicalTrials.gov registry entry for NCT04729504 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,116-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (79% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Adapted Project BRAVE is the first listed.

NCT04729504 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04729504 about?

NCT04729504 is a clinical study titled "Cultural Adaptation of a SSI for Youth Anxiety". The overarching objective of this protocol is to (1) adapt and (2) disseminate an evidence-based, brief (approximately 30 minute) single session intervention (SSI) to better reflect the cultural and linguistic diversity of Latin, Haitian, and Haitian-American individuals via a fully online platform.

What is the current status of trial NCT04729504?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2021-03-08. Estimated completion is 2026-12-21.

What conditions does trial NCT04729504 study?

This clinical trial studies the following conditions: Anxiety Disorders.

What interventions are being tested in trial NCT04729504?

The interventions under investigation include: Adapted Project BRAVE (BEHAVIORAL).

Who is sponsoring clinical trial NCT04729504?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04729504 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.